These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 24497351)

  • 1. The lupus biomarker odyssey: one experience.
    Ahearn JM; Manzi S; Liu CC
    Methods Mol Biol; 2014; 1134():17-35. PubMed ID: 24497351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reticulocytes bearing C4d as biomarkers of disease activity for systemic lupus erythematosus.
    Liu CC; Manzi S; Kao AH; Navratil JS; Ruffing MJ; Ahearn JM
    Arthritis Rheum; 2005 Oct; 52(10):3087-99. PubMed ID: 16200588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biomarkers for systemic lupus erythematosus.
    Ahearn JM; Liu CC; Kao AH; Manzi S
    Transl Res; 2012 Apr; 159(4):326-42. PubMed ID: 22424435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complement and lupus: old concepts and new directions.
    Porcel JM; Vergani D
    Lupus; 1992 Dec; 1(6):343-9. PubMed ID: 1304401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biomarkers in systemic lupus erythematosus: II. Markers of disease activity.
    Illei GG; Tackey E; Lapteva L; Lipsky PE
    Arthritis Rheum; 2004 Jul; 50(7):2048-65. PubMed ID: 15248202
    [No Abstract]   [Full Text] [Related]  

  • 6. Anti-C1q autoantibodies amplify pathogenic complement activation in systemic lupus erythematosus.
    Holers VM
    J Clin Invest; 2004 Sep; 114(5):616-9. PubMed ID: 15343378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Detection of leukocyte and platelet antibodies in systemic lupus erythematosus and related syndromes].
    Mayer S; Souissi T; Tongio MM; Berrebi A
    Nouv Rev Fr Hematol; 1971; 11(5):701-16. PubMed ID: 4114387
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunopathogenesis of systemic lupus erythematosus.
    Koffler D
    Annu Rev Med; 1974; 25():149-64. PubMed ID: 4132884
    [No Abstract]   [Full Text] [Related]  

  • 9. [Biological diagnosis of systemic lupus erythematosus].
    Hilliquin P; Weill BJ
    Ann Med Interne (Paris); 1991; 142(7):515-20. PubMed ID: 1789530
    [No Abstract]   [Full Text] [Related]  

  • 10. Measurement of cell-bound complement activation products enhances diagnostic performance in systemic lupus erythematosus.
    Kalunian KC; Chatham WW; Massarotti EM; Reyes-Thomas J; Harris C; Furie RA; Chitkara P; Putterman C; Gross RL; Somers EC; Kirou KA; Ramsey-Goldman R; Hsieh C; Buyon JP; Dervieux T; Weinstein A
    Arthritis Rheum; 2012 Dec; 64(12):4040-7. PubMed ID: 22932861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic lupus erythematosus. Laboratory studies.
    Rothfield NF
    Arthritis Rheum; 1977 Mar; 20(2 Suppl):299-303. PubMed ID: 400830
    [No Abstract]   [Full Text] [Related]  

  • 12. Increased C1q, C4 and C3 deposition on platelets in patients with systemic lupus erythematosus--a possible link to venous thrombosis?
    Lood C; Eriksson S; Gullstrand B; Jönsen A; Sturfelt G; Truedsson L; Bengtsson AA
    Lupus; 2012 Nov; 21(13):1423-32. PubMed ID: 22878256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Promising biomarkers for systemic lupus erythematosus.
    Jung JY; Bae CB; Suh CH
    Expert Opin Med Diagn; 2013 Nov; 7(6):601-13. PubMed ID: 24099307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Customising an antibody leukocyte capture microarray for systemic lupus erythematosus: beyond biomarker discovery.
    Ho JW; Lin MW; Braet F; Su YY; Adelstein S; dos Remedios CG
    Proteomics Clin Appl; 2010 Feb; 4(2):179-89. PubMed ID: 21137042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell-bound complement activation products as lupus biomarkers: diagnosis, monitoring and stratification.
    Ahearn JM; Liu CC; Manzi S
    Expert Rev Clin Immunol; 2017 Dec; 13(12):1133-1142. PubMed ID: 29025354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Progress in clinical tests and the pathophysiological tests of collagen diseases--complement].
    Horiuchi T; Tsukamoto H
    Nihon Naika Gakkai Zasshi; 1998 Dec; 87(12):2427-33. PubMed ID: 9922662
    [No Abstract]   [Full Text] [Related]  

  • 17. Complement deficiencies and systemic lupus erythematosus.
    Truedsson L; Bengtsson AA; Sturfelt G
    Autoimmunity; 2007 Dec; 40(8):560-6. PubMed ID: 18075790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Activated complement in systemic lupus erythematosus].
    Porcel JM; Ordi J
    Med Clin (Barc); 1991 Feb; 96(4):135-7. PubMed ID: 2023487
    [No Abstract]   [Full Text] [Related]  

  • 19. Antiphospholipid syndrome and systemic lupus erythematosus: are they separate entities or just clinical presentations on the same scale?
    Shoenfeld Y; Meroni PL; Toubi E
    Curr Opin Rheumatol; 2009 Sep; 21(5):495-500. PubMed ID: 19593144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progression of lupus-like disease drives the appearance of complement-activating IgG antibodies in MRL/lpr mice.
    Papp K; Végh P; Tchorbanov A; Vassilev T; Erdei A; Prechl J
    Rheumatology (Oxford); 2010 Dec; 49(12):2273-80. PubMed ID: 20736228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.